Moolec Science (MLEC) Accounts Payables (2022 - 2025)
Moolec Science's (MLEC) quarterly Accounts Payables came in at $7.3 million in Q2 2025, down 95.66% year-on-year from $168.9 million in Q2 2024, and up 660.04% quarter-over-quarter from $963631.0 in Q4 2024.
Moolec Science (MLEC) Accounts Payables (2022 - 2025) Analysis & Trends
Moolec Science has disclosed Accounts Payables across 4 years of filings, most recently posting $7.3 million for Q2 2025.
- Accounts Payables for Q2 2025 came in at $7.3 million, down 95.66% year-over-year; the trailing twelve-month figure through Jun 2025 was $7.3 million (down 95.66% YoY), and the FY2025 annual result was $7.3 million, down 95.66% from the prior year.
- Accounts Payables came in at $7.3 million for Q2 2025 at Moolec Science, up from $963631.0 in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $168.9 million in Q2 2024 to a low of -$4.2 million in Q1 2024.
- The 4-year median for Accounts Payables is $926711.0 (2022), against an average of $14.2 million.
- Peak annual rise in Accounts Payables reached 2158.64% in 2024, while the deepest fall reached 400.01% in 2024.
- Moolec Science's Accounts Payables stood at $4.2 million in 2022, then slumped by 166.5% to -$2.8 million in 2023, then jumped by 134.8% to $963631.0 in 2024, then surged by 660.04% to $7.3 million in 2025.
- The last three Accounts Payables figures came in at $7.3 million (Q2 2025), $963631.0 (Q4 2024), and -$701192.0 (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 1.05 Mn |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 83.00 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 8.64 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 489.30 Mn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 34.55 Mn |
| 10 | Moolec Science | 6.98 Bn | 6.98 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 7.32 Mn |
| Dec 31, 2024 | 963,631.00 |
| Sep 30, 2024 | -701,192.00 |
| Jun 30, 2024 | 168.94 Mn |
| Mar 31, 2024 | -4.16 Mn |
| Dec 31, 2023 | -2.77 Mn |
| Sep 30, 2023 | 292,432.00 |
| Jun 30, 2023 | 7.48 Mn |
| Mar 31, 2023 | 1.38 Mn |
| Dec 31, 2022 | 4.16 Mn |
| Sep 30, 2022 | 106,219.00 |
| Jun 30, 2022 | 926,711.00 |
| Mar 31, 2022 | 357,860.00 |